Vaxart CEO’s Insider Buying Signals Long‑Term Confidence in Oral Vaccine Breakthrough
CEO Lo Steven’s new Vaxart insider buys signal strong confidence in the oral vaccine platform, hinting at upcoming milestones that could lift the stock.
4 minutes to read